Contact network structure explains the changing epidemiology of pertussis

Science

Volumn 330, Issue 6006, 2010, Pages 982-985

  Rohani, Pejman ^a,b   Zhong, Xue ^a   King, Aaron A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE;

AGE STRUCTURE; BACTERIAL DISEASE; DATA SET; EPIDEMIOLOGY; HEALTH POLICY; INFANT MORTALITY; INFECTIOUS DISEASE; NETWORK ANALYSIS; VACCINE;

AGE DISTRIBUTION; ARTICLE; CHILD; EPIDEMIOLOGICAL DATA; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFANT; INFANT MORTALITY; INFECTION RISK; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD; SWEDEN; VACCINATION;

ADOLESCENT; AGE DISTRIBUTION; AGE FACTORS; CHILD; CHILD, PRESCHOOL; EUROPE; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; INTERPERSONAL RELATIONS; MODELS, STATISTICAL; PERTUSSIS VACCINE; PREVALENCE; SWEDEN; VACCINES, ACELLULAR; WHOOPING COUGH; YOUNG ADULT;

EID: 78149372436     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1194134     Document Type: Article

References (33)

1. L. P. Celentano, M. Massari, D. Paramatti, S. Salmaso, A. E. Tozzi; EUVAC-NET Group, Pediatr. Infect. Dis. J. 24, 761 (2005).
2. N. S. Crowcroft, C. Stein, P. Duclos, M. Birmingham, Lancet Infect. Dis. 3, 413 (2003).
3. N. S. Crowcroft, R. G. Pebody, Lancet 367, 1926 (2006).
4. J. D. Cherry, Pediatrics 112, 405 (2003).
5. H. O. Hallander, A. Advani, D. Donnelly, L. Gustafsson, R.-M. Carlsson, J. Clin. Microbiol. 43, 2856 (2005).
6. F. R. Mooi, I. H. van Loo, A. J. King, Emerg. Infect. Dis. 7 (suppl.), 526 (2001).
7. T. Tan, E. Trindade, D. Skowronski, Pediatr. Infect. Dis. J. 24 (suppl.), S10 (2005).
8. H. J. Wearing, P. Rohani, PLoS Pathog. 5, e1000647 (2009).
9. S. B. Omer et al., JAMA 296, 1757 (2006).
10. B. Ntezayabo, G. De Serres, B. Duval, Pediatr. Infect. Dis. J. 22, 22 (2003).
11. V. Romanus, R. Jonsell, S. O. Bergquist, Pediatr. Infect. Dis. J. 6, 364 (1987).
12. E. J. Gangarosa et al., Lancet 351, 356 (1998).
13. R.-M. Carlsson, B. Trollfors, Vaccine 27, 5709 (2009).
14. J. Mossong et al., PLoS Med. 5, e74 (2008).
15. D. M. Skowronski et al., J. Infect. Dis. 185, 1448 (2002).
16. D. Güris et al., Clin. Infect. Dis. 28, 1230 (1999).
17. D. Schenzle, IMA J. Math. Appl. Med. Biol. 1, 169 (1984).
18. R. Anderson, R. May, Infectious Diseases of Humans: Dynamics and Control (Oxford Univ. Press, Oxford, 1991).
19. M. Keeling, P. Rohani, Modelling Infectious Diseases (Princeton Univ. Press, Princeton, NJ, 2008).
20. R. M. Anderson, R. M. May, J. Hyg. (London) 94, 365 (1985).
21. W. J. Edmunds, N. J. Gay, M. Kretzschmar, R. G. Pebody, H. Wachmann; ESEN Project. European Sero-epidemiology Network, Epidemiol. Infect. 125, 635 (2000).
22. J. Wallinga, J. C. M. Heijne, M. Kretzschmar, PLoS Med. 2, e316 (2005).
23. J. D. Cherry, L. J. Baraff, E. Hewlett, West. J. Med. 150, 319 (1989).
24. K. Kretsinger et al., MMWR Recomm. Rep. 55 (RR-17), 1 (2006).
25. J. D. Nelson, Am. J. Dis. Child. 132, 371 (1978).
26. J. G. Deville et al., Clin. Infect. Dis. 21, 639 (1995).
27. C. H. von König, S. Halperin, M. Riffelmann, N. Guiso, Lancet Infect. Dis. 2, 744 (2002).
28. J. Schellekens, C. H. von König, P. Gardner, Pediatr. Infect. Dis. J. 24 (suppl.), S19 (2005).
29. H. Broutin, P. Rohani, J.-F. Guégan, B. T. Grenfell, F. Simondon, Vaccine 22, 594 (2004).
30. H. Broutin, C. Viboud, B. T. Grenfell, M. A. Miller, P. Rohani, Proc. Biol. Sci. 277, 3239 (2010).
31. P. E. Fine, J. A. Clarkson, Lancet 1, 666 (1982).
32. T. Eidlitz-Markus, M. Mimouni, A. Zeharia, Clin. Pediatr. (Phila.) 46, 718 (2007).
33. We thank three anonymous reviewers for comments. P.R. and A.A.K. are supported by the Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. P.R. was also supported by the Vaccine Modeling Initiative of the Bill & Melinda Gates Foundation.